デフォルト表紙
市場調査レポート
商品コード
1061301

世界のワクチン受託製造市場:考察と予測 (2028年まで)

Global Vaccine Contract Manufacturing Market Insights and Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 89 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
世界のワクチン受託製造市場:考察と予測 (2028年まで)
出版日: 2022年03月01日
発行: QYResearch
ページ情報: 英文 89 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ワクチン受託製造 (Vaccine Contract Manufacturing) 市場について調査しており、市場規模や動向の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界のワクチン受託製造の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Fill-Finish
    • Bulk Product
  • 市場:アプリケーション別
    • 世界のワクチン受託製造の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Pharmaceutical Companies
    • Biotech Companies
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のワクチン受託製造の市場展望 (2017-2028)
  • ワクチン受託製造の市場成長トレンド:地域別
    • ワクチン受託製造 市場規模:地域別: 2017 VS 2021 VS 2028
    • ワクチン受託製造の市場規模実績:地域別 (2017-2022)
    • ワクチン受託製造の市場規模予測:地域別 (2023-2028)
  • ワクチン受託製造 市場動向
    • ワクチン受託製造 業界動向
    • ワクチン受託製造 市場の促進要因
    • ワクチン受託製造 市場の課題
    • ワクチン受託製造 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界のワクチン受託製造の上位企業:収益別
    • 世界のワクチン受託製造の上位企業:収益別 (2017-2022)
    • 世界のワクチン受託製造の収益シェア:企業別 (2017-2022)
  • 世界のワクチン受託製造の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:ワクチン受託製造の収益
  • 世界のワクチン受託製造 市場集中度
    • 世界のワクチン受託製造 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: ワクチン受託製造の収益 2021
  • ワクチン受託製造の主要企業の本社および事業エリア
  • 主要企業 ワクチン受託製造の製品ソリューションおよびサービス
  • 市場参入時期: ワクチン受託製造 市場
  • M&A, 拡張計画

第4章 ワクチン受託製造 内訳データ:タイプ別

  • 世界のワクチン受託製造の市場規模実績:タイプ別 (2017-2022)
  • 世界のワクチン受託製造の市場規模予測:タイプ別 (2023-2028)

第5章 ワクチン受託製造 内訳データ:アプリケーション別

  • 世界のワクチン受託製造の市場規模実績:アプリケーション別 (2017-2022)
  • 世界のワクチン受託製造の市場規模予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のワクチン受託製造 市場規模 (2017-2028)
  • 北米のワクチン受託製造 市場規模:タイプ別
    • 北米のワクチン受託製造 市場規模:タイプ別 (2017-2022)
    • 北米のワクチン受託製造 市場規模:タイプ別 (2023-2028)
    • 北米のワクチン受託製造の市場シェア:タイプ別 (2017-2028)
  • 北米のワクチン受託製造 市場規模:アプリケーション別
    • 北米のワクチン受託製造 市場規模:アプリケーション別 (2017-2022)
    • 北米のワクチン受託製造 市場規模:アプリケーション別 (2023-2028)
    • 北米のワクチン受託製造の市場シェア:アプリケーション別 (2017-2028)
  • 北米のワクチン受託製造 市場規模:国別
    • 北米のワクチン受託製造 市場規模:国別 (2017-2022)
    • 北米のワクチン受託製造 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のワクチン受託製造 市場規模 (2017-2028)
  • 欧州のワクチン受託製造 市場規模:タイプ別
    • 欧州のワクチン受託製造 市場規模:タイプ別 (2017-2022)
    • 欧州のワクチン受託製造 市場規模:タイプ別 (2023-2028)
    • 欧州のワクチン受託製造の市場シェア:タイプ別 (2017-2028)
  • 欧州のワクチン受託製造 市場規模:アプリケーション別
    • 欧州のワクチン受託製造 市場規模:アプリケーション別 (2017-2022)
    • 欧州のワクチン受託製造 市場規模:アプリケーション別 (2023-2028)
    • 欧州のワクチン受託製造の市場シェア:アプリケーション別 (2017-2028)
  • 欧州のワクチン受託製造 市場規模:国別
    • 欧州のワクチン受託製造 市場規模:国別 (2017-2022)
    • 欧州のワクチン受託製造 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 ワクチン受託製造 市場規模 (2017-2028)
  • アジア太平洋地域 ワクチン受託製造 市場規模:タイプ別
    • アジア太平洋地域 ワクチン受託製造 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 ワクチン受託製造 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 ワクチン受託製造の市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 ワクチン受託製造 市場規模:アプリケーション別
    • アジア太平洋地域 ワクチン受託製造 市場規模:アプリケーション別 (2017-2022)
    • アジア太平洋地域 ワクチン受託製造 市場規模:アプリケーション別 (2023-2028)
    • アジア太平洋地域 ワクチン受託製造の市場シェア:アプリケーション別 (2017-2028)
  • アジア太平洋地域 ワクチン受託製造 市場規模:地域別
    • アジア太平洋地域 ワクチン受託製造 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 ワクチン受託製造 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのワクチン受託製造 市場規模 (2017-2028)
  • ラテンアメリカのワクチン受託製造 市場規模:タイプ別
    • ラテンアメリカのワクチン受託製造 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカのワクチン受託製造 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカのワクチン受託製造の市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカのワクチン受託製造 市場規模:アプリケーション別
    • ラテンアメリカのワクチン受託製造 市場規模:アプリケーション別 (2017-2022)
    • ラテンアメリカのワクチン受託製造 市場規模:アプリケーション別 (2023-2028)
    • ラテンアメリカのワクチン受託製造の市場シェア:アプリケーション別 (2017-2028)
  • ラテンアメリカのワクチン受託製造 市場規模:国別
    • ラテンアメリカのワクチン受託製造 市場規模:国別 (2017-2022)
    • ラテンアメリカのワクチン受託製造 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのワクチン受託製造 市場規模 (2017-2028)
  • 中東・アフリカのワクチン受託製造 市場規模:タイプ別
    • 中東・アフリカのワクチン受託製造 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカのワクチン受託製造 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカのワクチン受託製造の市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカのワクチン受託製造 市場規模:アプリケーション別
    • 中東・アフリカのワクチン受託製造 市場規模:アプリケーション別 (2017-2022)
    • 中東・アフリカのワクチン受託製造 市場規模:アプリケーション別 (2023-2028)
    • 中東・アフリカのワクチン受託製造の市場シェア:アプリケーション別 (2017-2028)
  • 中東・アフリカのワクチン受託製造 市場規模:国別
    • 中東・アフリカのワクチン受託製造 市場規模:国別 (2017-2022)
    • 中東・アフリカのワクチン受託製造 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Diosynth
  • Emergent BioSolutions
  • Goodwin Biotechnology
  • Bavarian Nordic
  • Soligenix Inc
  • Catalent Biologics

第12章 アナリストによる分析/結論

第13章 付録

図表

LIST OF TABLES

List of Tables

  • Table 1. Global Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Fill-Finish
  • Table 3. Key Players of Bulk Product
  • Table 4. Global Vaccine Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Vaccine Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Vaccine Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Vaccine Contract Manufacturing Market Share by Region (2017-2022)
  • Table 8. Global Vaccine Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Vaccine Contract Manufacturing Market Share by Region (2023-2028)
  • Table 10. Vaccine Contract Manufacturing Market Trends
  • Table 11. Vaccine Contract Manufacturing Market Drivers
  • Table 12. Vaccine Contract Manufacturing Market Challenges
  • Table 13. Vaccine Contract Manufacturing Market Restraints
  • Table 14. Global Vaccine Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Vaccine Contract Manufacturing Revenue Share by Players (2017-2022)
  • Table 16. Global Top Vaccine Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2021)
  • Table 17. Ranking of Global Top Vaccine Contract Manufacturing Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Vaccine Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Vaccine Contract Manufacturing Product Solution and Service
  • Table 21. Date of Enter into Vaccine Contract Manufacturing Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Vaccine Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2017-2022)
  • Table 25. Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2023-2028)
  • Table 27. Global Vaccine Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Vaccine Contract Manufacturing Revenue Share by Application (2017-2022)
  • Table 29. Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Vaccine Contract Manufacturing Revenue Share by Application (2023-2028)
  • Table 31. North America Vaccine Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Vaccine Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Vaccine Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Vaccine Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Vaccine Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Vaccine Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Vaccine Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Vaccine Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Vaccine Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Vaccine Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Vaccine Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Vaccine Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Vaccine Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Vaccine Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Vaccine Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Vaccine Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Vaccine Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Vaccine Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Vaccine Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Vaccine Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Vaccine Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Vaccine Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Vaccine Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Vaccine Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Vaccine Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Vaccine Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Vaccine Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Vaccine Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Vaccine Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Vaccine Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Diosynth Company Details
  • Table 62. Diosynth Business Overview
  • Table 63. Diosynth Vaccine Contract Manufacturing Product
  • Table 64. Diosynth Revenue in Vaccine Contract Manufacturing Business (2017-2022) & (US$ Million)
  • Table 65. Diosynth Recent Developments
  • Table 66. Emergent BioSolutions Company Details
  • Table 67. Emergent BioSolutions Business Overview
  • Table 68. Emergent BioSolutions Vaccine Contract Manufacturing Product
  • Table 69. Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2017-2022) & (US$ Million)
  • Table 70. Emergent BioSolutions Recent Developments
  • Table 71. Goodwin Biotechnology Company Details
  • Table 72. Goodwin Biotechnology Business Overview
  • Table 73. Goodwin Biotechnology Vaccine Contract Manufacturing Product
  • Table 74. Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2017-2022) & (US$ Million)
  • Table 75. Goodwin Biotechnology Recent Developments
  • Table 76. Bavarian Nordic Company Details
  • Table 77. Bavarian Nordic Business Overview
  • Table 78. Bavarian Nordic Vaccine Contract Manufacturing Product
  • Table 79. Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2017-2022) & (US$ Million)
  • Table 80. Bavarian Nordic Recent Developments
  • Table 81. Soligenix Inc Company Details
  • Table 82. Soligenix Inc Business Overview
  • Table 83. Soligenix Inc Vaccine Contract Manufacturing Product
  • Table 84. Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2017-2022) & (US$ Million)
  • Table 85. Soligenix Inc Recent Developments
  • Table 86. Catalent Biologics Company Details
  • Table 87. Catalent Biologics Business Overview
  • Table 88. Catalent Biologics Vaccine Contract Manufacturing Product
  • Table 89. Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2017-2022) & (US$ Million)
  • Table 90. Catalent Biologics Recent Developments
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Vaccine Contract Manufacturing Market Share by Type: 2021 VS 2028
  • Figure 2. Fill-Finish Features
  • Figure 3. Bulk Product Features
  • Figure 4. Global Vaccine Contract Manufacturing Market Share by Application: 2021 VS 2028
  • Figure 5. Pharmaceutical Companies Case Studies
  • Figure 6. Biotech Companies Case Studies
  • Figure 7. Others Case Studies
  • Figure 8. Vaccine Contract Manufacturing Report Years Considered
  • Figure 9. Global Vaccine Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Vaccine Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Vaccine Contract Manufacturing Market Share by Region: 2021 VS 2028
  • Figure 12. Global Vaccine Contract Manufacturing Market Share by Players in 2021
  • Figure 13. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Contract Manufacturing as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2021
  • Figure 15. North America Vaccine Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Vaccine Contract Manufacturing Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Vaccine Contract Manufacturing Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Vaccine Contract Manufacturing Market Size Share by Country (2017-2028)
  • Figure 19. United States Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Vaccine Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Vaccine Contract Manufacturing Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Vaccine Contract Manufacturing Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Vaccine Contract Manufacturing Market Size Share by Country (2017-2028)
  • Figure 25. Germany Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Vaccine Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Vaccine Contract Manufacturing Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Vaccine Contract Manufacturing Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Vaccine Contract Manufacturing Market Size Share by Region (2017-2028)
  • Figure 35. China Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Latin America Vaccine Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Vaccine Contract Manufacturing Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Vaccine Contract Manufacturing Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Vaccine Contract Manufacturing Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Vaccine Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Vaccine Contract Manufacturing Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Vaccine Contract Manufacturing Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Vaccine Contract Manufacturing Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Vaccine Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Diosynth Revenue Growth Rate in Vaccine Contract Manufacturing Business (2017-2022)
  • Figure 55. Emergent BioSolutions Revenue Growth Rate in Vaccine Contract Manufacturing Business (2017-2022)
  • Figure 56. Goodwin Biotechnology Revenue Growth Rate in Vaccine Contract Manufacturing Business (2017-2022)
  • Figure 57. Bavarian Nordic Revenue Growth Rate in Vaccine Contract Manufacturing Business (2017-2022)
  • Figure 58. Soligenix Inc Revenue Growth Rate in Vaccine Contract Manufacturing Business (2017-2022)
  • Figure 59. Catalent Biologics Revenue Growth Rate in Vaccine Contract Manufacturing Business (2017-2022)
  • Figure 60. Bottom-up and Top-down Approaches for This Report
  • Figure 61. Data Triangulation
  • Figure 62. Key Executives Interviewed
目次

Market Analysis and Insights: Global Vaccine Contract Manufacturing Market

The global Vaccine Contract Manufacturing market size is projected to reach US$ 2558.5 million by 2028, from US$ 1731.5 million in 2021, at a CAGR of 5.3% during 2022-2028.

Fully considering the economic change by this health crisis, Fill-Finish accounting for % of the Vaccine Contract Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical Companies segment is altered to an % CAGR throughout this forecast period.

China Vaccine Contract Manufacturing market size is valued at US$ million in 2021, while the North America and Europe Vaccine Contract Manufacturing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vaccine Contract Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaccine Contract Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaccine Contract Manufacturing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaccine Contract Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaccine Contract Manufacturing market.

Global Vaccine Contract Manufacturing Scope and Market Size

Vaccine Contract Manufacturing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Vaccine Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Fill-Finish
  • Bulk Product

Segment by Application

  • Pharmaceutical Companies
  • Biotech Companies
  • Others

By Company

  • Diosynth
  • Emergent BioSolutions
  • Goodwin Biotechnology
  • Bavarian Nordic
  • Soligenix Inc
  • Catalent Biologics

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Fill-Finish
    • 1.2.3 Bulk Product
  • 1.3 Market by Application
    • 1.3.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Biotech Companies
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Vaccine Contract Manufacturing Market Perspective (2017-2028)
  • 2.2 Vaccine Contract Manufacturing Growth Trends by Region
    • 2.2.1 Vaccine Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Vaccine Contract Manufacturing Historic Market Size by Region (2017-2022)
    • 2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Region (2023-2028)
  • 2.3 Vaccine Contract Manufacturing Market Dynamics
    • 2.3.1 Vaccine Contract Manufacturing Industry Trends
    • 2.3.2 Vaccine Contract Manufacturing Market Drivers
    • 2.3.3 Vaccine Contract Manufacturing Market Challenges
    • 2.3.4 Vaccine Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
    • 3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2017-2022)
    • 3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
  • 3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
    • 3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2021
  • 3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
  • 3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
  • 3.7 Date of Enter into Vaccine Contract Manufacturing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Vaccine Contract Manufacturing Breakdown Data by Type

  • 4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2017-2022)
  • 4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2023-2028)

5 Vaccine Contract Manufacturing Breakdown Data by Application

  • 5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2017-2022)
  • 5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Vaccine Contract Manufacturing Market Size (2017-2028)
  • 6.2 North America Vaccine Contract Manufacturing Market Size by Type
    • 6.2.1 North America Vaccine Contract Manufacturing Market Size by Type (2017-2022)
    • 6.2.2 North America Vaccine Contract Manufacturing Market Size by Type (2023-2028)
    • 6.2.3 North America Vaccine Contract Manufacturing Market Share by Type (2017-2028)
  • 6.3 North America Vaccine Contract Manufacturing Market Size by Application
    • 6.3.1 North America Vaccine Contract Manufacturing Market Size by Application (2017-2022)
    • 6.3.2 North America Vaccine Contract Manufacturing Market Size by Application (2023-2028)
    • 6.3.3 North America Vaccine Contract Manufacturing Market Share by Application (2017-2028)
  • 6.4 North America Vaccine Contract Manufacturing Market Size by Country
    • 6.4.1 North America Vaccine Contract Manufacturing Market Size by Country (2017-2022)
    • 6.4.2 North America Vaccine Contract Manufacturing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Vaccine Contract Manufacturing Market Size (2017-2028)
  • 7.2 Europe Vaccine Contract Manufacturing Market Size by Type
    • 7.2.1 Europe Vaccine Contract Manufacturing Market Size by Type (2017-2022)
    • 7.2.2 Europe Vaccine Contract Manufacturing Market Size by Type (2023-2028)
    • 7.2.3 Europe Vaccine Contract Manufacturing Market Share by Type (2017-2028)
  • 7.3 Europe Vaccine Contract Manufacturing Market Size by Application
    • 7.3.1 Europe Vaccine Contract Manufacturing Market Size by Application (2017-2022)
    • 7.3.2 Europe Vaccine Contract Manufacturing Market Size by Application (2023-2028)
    • 7.3.3 Europe Vaccine Contract Manufacturing Market Share by Application (2017-2028)
  • 7.4 Europe Vaccine Contract Manufacturing Market Size by Country
    • 7.4.1 Europe Vaccine Contract Manufacturing Market Size by Country (2017-2022)
    • 7.4.2 Europe Vaccine Contract Manufacturing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2017-2028)
  • 8.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type
    • 8.2.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Vaccine Contract Manufacturing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application
    • 8.3.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Vaccine Contract Manufacturing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region
    • 8.4.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Vaccine Contract Manufacturing Market Size (2017-2028)
  • 9.2 Latin America Vaccine Contract Manufacturing Market Size by Type
    • 9.2.1 Latin America Vaccine Contract Manufacturing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Vaccine Contract Manufacturing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Vaccine Contract Manufacturing Market Share by Type (2017-2028)
  • 9.3 Latin America Vaccine Contract Manufacturing Market Size by Application
    • 9.3.1 Latin America Vaccine Contract Manufacturing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Vaccine Contract Manufacturing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Vaccine Contract Manufacturing Market Share by Application (2017-2028)
  • 9.4 Latin America Vaccine Contract Manufacturing Market Size by Country
    • 9.4.1 Latin America Vaccine Contract Manufacturing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Vaccine Contract Manufacturing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2017-2028)
  • 10.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type
    • 10.2.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Vaccine Contract Manufacturing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application
    • 10.3.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Vaccine Contract Manufacturing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country
    • 10.4.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Diosynth
    • 11.1.1 Diosynth Company Details
    • 11.1.2 Diosynth Business Overview
    • 11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
    • 11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2017-2022)
    • 11.1.5 Diosynth Recent Developments
  • 11.2 Emergent BioSolutions
    • 11.2.1 Emergent BioSolutions Company Details
    • 11.2.2 Emergent BioSolutions Business Overview
    • 11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
    • 11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2017-2022)
    • 11.2.5 Emergent BioSolutions Recent Developments
  • 11.3 Goodwin Biotechnology
    • 11.3.1 Goodwin Biotechnology Company Details
    • 11.3.2 Goodwin Biotechnology Business Overview
    • 11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
    • 11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2017-2022)
    • 11.3.5 Goodwin Biotechnology Recent Developments
  • 11.4 Bavarian Nordic
    • 11.4.1 Bavarian Nordic Company Details
    • 11.4.2 Bavarian Nordic Business Overview
    • 11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
    • 11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2017-2022)
    • 11.4.5 Bavarian Nordic Recent Developments
  • 11.5 Soligenix Inc
    • 11.5.1 Soligenix Inc Company Details
    • 11.5.2 Soligenix Inc Business Overview
    • 11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
    • 11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2017-2022)
    • 11.5.5 Soligenix Inc Recent Developments
  • 11.6 Catalent Biologics
    • 11.6.1 Catalent Biologics Company Details
    • 11.6.2 Catalent Biologics Business Overview
    • 11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
    • 11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2017-2022)
    • 11.6.5 Catalent Biologics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer